On March 25, 2010, CorMedix announced the pricing of its initial public offering of 1,925,000 units at $6.50 per unit. Each unit consisted of two shares of CorMedix common stock and a warrant to purchase one share of common stock at a price of $3.4375.
CorMedix’s common stock is traded on the Nasdaq Global Market under the ticker symbol CRMD.
The CUSIP number for CorMedix’s common stock is 21900C308.
At this time, CorMedix does not have a direct purchase program. CorMedix stock may be purchased through a broker or a financial institution that deals in securities.
The transfer agent and registrar for CorMedix’s common stock is VStock Transfer, LLC. The contact information for VStock Transfer is 18 Lafayette Place, Woodmere, New York 11598, 212-828-8436.
CorMedix Inc. was founded in 2006 and is now based in Berkeley Heights, New Jersey.